Global Anticoccidial Drugs Market in Animal Health- Market Dynamics
In the veterinary antibiotic market, the market for food producing animals accounted for nearly 80% of the total market in 2011. This has increased the demand for anticoccidial drugs, largely due to the increased incidence of coccidiosis and other protozoan parasite based diseases that infect majorly food producing organisms but are not limited to them. In the poultry and cattle markets, the incidence of coccidiosis has cost millions of dollars in treatment and preventive care. Also, the trend of owning companion animals is also contributing to the increasing use of anticoccidials, as dogs, cats and occasionally even horses are prone to coccidiosis and if left untreated, it could lead to the death of the animal.
Some of the other factors driving this market are:
Increase in global population
Increase in the per capita global consumption of meat
Increased adoption of intensive farming methods
The global anticoccidial market has been segmented on the basis of animal type (poultry, cattle, swine, and companion animals), drugs (ionophore anticoccidials, chemical derivative anticoccidials, and antibiotic anticoccidials), and by geography (North America, Europe, Asia-Pacific and Rest of the World).
The Asia-Pacific region is set to be the largest contributor in terms of total revenue in this market by the year 2020. The countries set to be major contributors in this region are China, India, Japan, and Australia. The growth in the North American and European markets is set to be stagnant due to the stagnated market and government restrictions.
This Report Offers:
Market definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the anticoccidial drugs market in the healthcare industry, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the anticoccidial drugs market in the healthcare industry on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
2. Market Definition
3. Market Drivers
4. Market Restraints
5. Market opportunities
6. Anticoccidial drugs
6.2 Global market
6.3 Coccidiosis in Poultry
6.3.1 Commonly used anticoccidials in poultry
6.3.2 Drug administration modes and Dosage
6.4 Coccidiosis in Cattle
6.4.1 Commonly used anticoccidials in cattle
6.4.2 Drug administration modes and dosage
6.4.3 Commonly used coccidiostats in cattle
6.5 Coccidiosis in Swine
6.5.1 Commonly used anticoccidials in Swine
6.5.2 Drug Administration modes and dosage
6.6 Coccidiosis in companion animals
6.6.1 Coccidiosis in dogs
6.6.2 Coccidiosis in cats
6.6.3 Commonly used anticoccidials for Dogs, Dosage, and mode of administration
6.6.4 Commonly used anticoccidials for cats, dosage, and modes of Administration
6.7 Anticoccidials market by types of drugs
6.7.1 Ionophore anticoccidials
6.7.2 Chemical derivative anticoccidials
6.7.3 Antibiotic anticoccidials
7. Region-wise analysis of anticoccidial market (Market size, Forecast, and CAGR)
7.2 North America
7.5 South America
8. Segmentation by Animal Type - anticoccidial market (Market size, Forecast, and CAGR)
9 The future of anticoccidial market 10 Competitive Landscape
10.2 Top contenders in the market
10.3 top contenders in the market
11 Company Profiles
11.2 Elanco (A division of Eli Lilly and Company)
11.4 Bayer Healthcare Animal Healthcare division
11.5 Merck Animal Healthcare
11.6 Boehringer Ingelheim Animal Health
11.8 Ceva Animal Healthcare